Renalytix (RENX) News Today GBX 7.50 -0.25 (-3.23%) (As of 11:45 AM ET) Add Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Renalytix AI Targets Profitability with Kidney Test SalesNovember 21 at 6:08 AM | markets.businessinsider.comRenalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025November 21 at 1:06 AM | finanznachrichten.deRenalytix Reports Reduced Losses and Strong Financial OutlookNovember 21 at 1:06 AM | markets.businessinsider.comRenalytix PLC Sees Major Voting Rights ShiftNovember 7, 2024 | markets.businessinsider.comRenalytix Sees Major Shift in Voting RightsNovember 7, 2024 | markets.businessinsider.comRenalytix Appoints Julian Baines as Executive ChairmanNovember 5, 2024 | markets.businessinsider.comChristopher H. B. Mills Sells 83,696 Shares of Renalytix Plc (LON:RENX) StockOctober 13, 2024 | insidertrades.comCommencement of trading on OTCQB in the United StatesOctober 8, 2024 | finance.yahoo.comRenalytix (NASDAQ:RNLX) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comRenalytix AI plc (2O9.MU)August 29, 2024 | uk.finance.yahoo.comLatest News for Renalytix Stock (NASDAQ:RNLX)May 28, 2024 | benzinga.comIs Renalytix the best penny stock to buy today?March 9, 2024 | uk.finance.yahoo.comRNLX Mar 2024 2.500 callFebruary 17, 2024 | finance.yahoo.comRenalytix plc: Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024February 15, 2024 | finanznachrichten.deRenalytix AI plc (RENX)February 15, 2024 | uk.investing.comRenalytix Plc (RNLX) stock price, news, quote & history – Yahoo FinanceFebruary 14, 2024 | nz.finance.yahoo.comRenalytix PLC RENXFebruary 13, 2024 | morningstar.comAfter the Renalytix share price jumps 500% in 3 days, is it time to buy?February 13, 2024 | uk.finance.yahoo.comRenalytix plc: New published data demonstrates KidneyIntelX has broad implications for winning war on chronic kidney diseaseJanuary 10, 2024 | finanznachrichten.deRenalytix Stock (NASDAQ:RNLX) Earnings Dates and Earning CallsNovember 15, 2023 | benzinga.comRenalytix Reports Full Year Fiscal 2023 ResultsSeptember 28, 2023 | markets.businessinsider.comRenalytix Appoints Senior Executive Howard Doran as Chief Business OfficerSeptember 7, 2023 | finance.yahoo.comRenalytix Appoints Financial Executive Catherine Coste to its Board of DirectorsJuly 3, 2023 | finance.yahoo.comFDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney DiseaseJune 29, 2023 | finance.yahoo.comKidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific ConferencesJune 15, 2023 | finance.yahoo.comIs the Renalytix share price a bargain or a falling knife?May 31, 2023 | uk.movies.yahoo.comNew Published Real-World Evidence Shows KidneyIntelX(TM) UtilityApril 20, 2023 | marketwatch.comNew Published Real-World Evidence Shows KidneyIntelX™ UtilityApril 19, 2023 | finance.yahoo.comData Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical MeetingApril 12, 2023 | finance.yahoo.comRenalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial ResultsMarch 30, 2023 | finance.yahoo.comRenalytix Shares Fall on Delay to FDA Marketing Authorization Decision on KidneyIntelXMarch 21, 2023 | marketwatch.comRenalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceFebruary 9, 2023 | finance.yahoo.comRenalytix announces a c.$20.3 million private placementFebruary 8, 2023 | finance.yahoo.comRenalytix Shares Rise on $10 Mln Grant Award to Advance Chronic Kidney Disease TreatmentJanuary 26, 2023 | marketwatch.comRenalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United StatesJanuary 26, 2023 | finance.yahoo.comRenalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systemsJanuary 9, 2023 | finance.yahoo.comPrimary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and OutcomesDecember 1, 2022 | finance.yahoo.comRenalytix AI, Inc.: Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023November 30, 2022 | finanznachrichten.deWhat’s going on with the Renalytix share price?November 30, 2022 | msn.comRenalytix plc: Renalytix Reports Full Year Fiscal 2022 ResultsOctober 31, 2022 | finanznachrichten.deRenalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31October 24, 2022 | finance.yahoo.comRenalytix Announces Change to Board of DirectorsSeptember 20, 2022 | finance.yahoo.comRenalytix Plc (RENX.L)August 17, 2022 | uk.finance.yahoo.comData Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care PhysiciansAugust 8, 2022 | finance.yahoo.comHere’s why the Renalytix share price is tankingJune 30, 2022 | fool.co.ukRenalytix Reports Financial Results for Third Quarter of Fiscal Year 2022June 30, 2022 | finance.yahoo.comThe Renalytix share price – where next?June 16, 2022 | uk.finance.yahoo.com1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease PatientsJune 10, 2022 | finance.yahoo.comKidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient CohortJune 6, 2022 | finance.yahoo.comRenalytix Announces Two Data Presentations on KidneyIntelX(TM) at American Diabetes Association 82nd Scientific Sessions®June 3, 2022 | stockhouse.com Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin RENX Media Mentions By Week RENX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENX News Sentiment▼0.280.46▲Average Medical News Sentiment RENX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENX Articles This Week▼30▲RENX Articles Average Week Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:RENX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
